HomeCompareFPSVX vs JNJ

FPSVX vs JNJ: Dividend Comparison 2026

FPSVX yields 8.11% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FPSVX wins by $14.2K in total portfolio value
10 years
FPSVX
FPSVX
● Live price
8.11%
Share price
$24.67
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$1,354.31
Full FPSVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FPSVX vs JNJ

📍 FPSVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFPSVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FPSVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FPSVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FPSVX
Annual income on $10K today (after 15% tax)
$689.23/yr
After 10yr DRIP, annual income (after tax)
$1,151.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FPSVX beats the other by $447.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FPSVX + JNJ for your $10,000?

FPSVX: 50%JNJ: 50%
100% JNJ50/50100% FPSVX
Portfolio after 10yr
$27.1K
Annual income
$1,091.04/yr
Blended yield
4.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FPSVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FPSVX buys
0
JNJ buys
0
No recent congressional trades found for FPSVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFPSVXJNJ
Forward yield8.11%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.2K$20.0K
Annual income after 10y$1,354.31$827.78
Total dividends collected$10.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FPSVX vs JNJ ($10,000, DRIP)

YearFPSVX PortfolioFPSVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,511$810.86$10,676$355.77+$835.00FPSVX
2$13,189$872.31$11,407$389.39+$1.8KFPSVX
3$15,046$934.09$12,198$426.53+$2.8KFPSVX
4$17,095$995.91$13,056$467.62+$4.0KFPSVX
5$19,350$1,057.52$13,987$513.12+$5.4KFPSVX
6$21,823$1,118.66$14,998$563.56+$6.8KFPSVX
7$24,529$1,179.10$16,098$619.52+$8.4KFPSVX
8$27,485$1,238.64$17,295$681.69+$10.2KFPSVX
9$30,706$1,297.10$18,599$750.82+$12.1KFPSVX
10$34,210$1,354.31$20,022$827.78+$14.2KFPSVX

FPSVX vs JNJ: Complete Analysis 2026

FPSVXStock

The investment seeks long-term total investment return through capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in shares of common stock of small-capitalization companies, consistent with companies within the Russell 2000® Value Index. It will typically invest in 100 to 120 companies with initial weightings between 0.25% to 1.00% of the fund's total assets in order to have broad industry representation and reduce individual security risk within the fund.

Full FPSVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FPSVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FPSVX vs SCHDFPSVX vs JEPIFPSVX vs OFPSVX vs KOFPSVX vs MAINFPSVX vs ABBVFPSVX vs MRKFPSVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.